Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Caribou Biosciences (CRBU) Depreciation & Amortization (CF): 2020-2025

Historic Depreciation & Amortization (CF) for Caribou Biosciences (CRBU) over the last 6 years, with Sep 2025 value amounting to $631,000.

  • Caribou Biosciences' Depreciation & Amortization (CF) fell 46.39% to $631,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $4.1 million, marking a year-over-year increase of 19.06%. This contributed to the annual value of $3.9 million for FY2024, which is 11.40% up from last year.
  • As of Q3 2025, Caribou Biosciences' Depreciation & Amortization (CF) stood at $631,000, which was down 45.93% from $1.2 million recorded in Q2 2025.
  • In the past 5 years, Caribou Biosciences' Depreciation & Amortization (CF) ranged from a high of $1.6 million in Q3 2023 and a low of $221,000 during Q1 2021.
  • Over the past 3 years, Caribou Biosciences' median Depreciation & Amortization (CF) value was $856,000 (recorded in 2024), while the average stood at $946,818.
  • In the last 5 years, Caribou Biosciences' Depreciation & Amortization (CF) skyrocketed by 250.89% in 2023 and then slumped by 46.39% in 2025.
  • Caribou Biosciences' Depreciation & Amortization (CF) (Quarterly) stood at $273,000 in 2021, then skyrocketed by 85.35% to $506,000 in 2022, then surged by 46.25% to $740,000 in 2023, then spiked by 60.00% to $1.2 million in 2024, then plummeted by 46.39% to $631,000 in 2025.
  • Its Depreciation & Amortization (CF) stands at $631,000 for Q3 2025, versus $1.2 million for Q2 2025 and $1.2 million for Q1 2025.